The center currently tests only some patients’ tumors, screening them for specific genetic mutations that might provide a clue as to which treatment options could be most effective. Between two and three dozen cancer centers nationwide also do genetic tumor testing, according to the report.
At this time the center will focus on clinically actionable results rather than cancer genetic profiling research, meaning screening results will be used only to help physicians identify current treatment or a targeted treatment trial that fits the profile of a particular patient’s cancer.
Genetic testing is part of the new movement in creating cancer therapies that target specific genetic mutations in the quest to avoid the mass cellular devastation of chemotherapy.
More Articles on Key Specialties:
15 Oncology Center Openings and Expansions
Mercy, UH Rainbow Collaborate on Children’s Care
Orange Coast Memorial Opens Lung Cancer Screening Program
Becker’s 3rd Annual Fall Chief Pharmacy Officer Summit is the top tier event that the people leading the future of pharmacy convene. This 3-day event is built specifically for Chief Pharmacy Officers and senior pharmacy leaders. The sessions examine the workforce, financial and clinical priorities shaping pharmacy today. Becker’s is where candid discussions flourish and new ideas thrive. Becker's 3rd Annual Fall Chief Pharmacy Officer Summit
